ORC
PFE icon

O'Rourke & Company’s Pfizer PFE Stock Holding History

O'Rourke & Company’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$931K Buy
38,677
+2,267
+6% +$59.3K 0.33% 74
2026
Q1 		$1.02M Buy
36,410
+11,965
+49% +$319K 0.4% 62
2025
Q4 		$609K Buy
24,445
+6,400
+35% +$161K 0.24% 91
2025
Q3 		$460K Buy
18,045
+887
+5% +$21.9K 0.19% 103
2025
Q2 		$416K Sell
17,158
-611
-3% -$14.2K 0.19% 103
2025
Q1 		$450K Buy
17,769
+758
+4% +$19.8K 0.22% 93
2024
Q4 		$451K Sell
17,011
-1,779
-9% -$48.3K 0.22% 94
2024
Q3 		$544K Buy
18,790
+2,709
+17% +$79K 0.27% 76
2024
Q2 		$450K Buy
16,081
+5,430
+51% +$149K 0.25% 81
2024
Q1 		$296K Sell
10,651
-5,398
-34% -$150K 0.17% 113
2023
Q4 		$462K Sell
16,049
-5,048
-24% -$153K 0.3% 69
2023
Q3 		$700K Sell
21,097
-160
-0.8% -$5.66K 0.51% 44
2023
Q2 		$780K Buy
21,257
+430
+2% +$16.7K 0.55% 43
2023
Q1 		$850K Sell
20,827
-542
-3% -$23.4K 0.65% 37
2022
Q4 		$1.09M Buy
21,369
+2,165
+11% +$104K 0.87% 32
2022
Q3 		$840K Buy
19,204
+558
+3% +$27.1K 0.73% 34
2022
Q2 		$978K Sell
18,646
-1,249
-6% -$63.6K 0.83% 34
2022
Q1 		$1.03M Buy
19,895
+511
+3% +$26.5K 0.71% 37
2021
Q4 		$1.15M Buy
+19,384
New +$960K 0.76% 32

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

O'Rourke & Company's PFE Position: Q2 2026 in Review

O'Rourke & Company increased its Pfizer (PFE) stake by 6.2% in Q2 2026, buying an estimated $59.3K and bringing the position to 38,677 shares worth $931K. The position accounts for 0.33% of the portfolio, ranked #74.

O'Rourke & Company first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.15M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • O'Rourke & Company held 38,677 shares of Pfizer worth $931K as of Q2 2026.
  • O'Rourke & Company bought 2,267 Pfizer shares in Q2 2026, an estimated $59.3K.
  • Pfizer made up 0.33% of O'Rourke & Company's portfolio in Q2 2026, its #74 holding.
  • O'Rourke & Company first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • O'Rourke & Company's Pfizer position peaked at $1.15M in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on O'Rourke & Company's 13F filing for Q2 2026, filed 14 Aug 2026.